* For premature infants, the vaccination consists of three doses administered at intervals of at least one month between doses, followed by a fourth dose administered at least 6 months after the third dose (i.e., the 3+1 schedule).
** Against invasive meningococcal infections caused by group B meningococcus, provided vaccination is initiated before the child reaches 12 months of age.
*** For premature infants, vaccination is administered in three doses given at intervals of at least one month between doses, with a fourth dose given at least 6 months after the third dose (i.e., the 3+1 schedule).
**** Against invasive meningococcal infections caused by groups A, C, W, and Y, if vaccination is administered as a single dose between the ages of one and two years.
# Against invasive meningococcal infections caused by group B meningococcus, if vaccination is administered as a single dose between the ages of 14 and 15 years. Vaccination is covered if it was initiated at this age.
## Against invasive meningococcal infections of groups A, C, W, and Y, if vaccination is administered as a single dose between the ages of 14 and 15.
IMO – Invasive meningococcal disease
IPO – Invasive pneumococcal disease
Prevenar 13 (13-valent vaccine, 2+1 schedule)
Vaxneuvance (15-valent vaccine, 2+1 schedule)
Prevenar 20 (20-valent vaccine, 3+1 schedule)